CARAMORI, GAETANO
 Distribuzione geografica
Continente #
AS - Asia 9.169
NA - Nord America 5.219
SA - Sud America 2.107
EU - Europa 1.734
AF - Africa 580
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.833
Nazione #
US - Stati Uniti d'America 4.948
SG - Singapore 4.541
BR - Brasile 1.557
VN - Vietnam 1.413
HK - Hong Kong 984
CN - Cina 918
ZA - Sudafrica 413
NL - Olanda 383
IT - Italia 382
BD - Bangladesh 366
FR - Francia 358
AR - Argentina 213
IN - India 201
RU - Federazione Russa 194
DE - Germania 103
MX - Messico 99
CA - Canada 97
IQ - Iraq 91
EC - Ecuador 87
GB - Regno Unito 80
TR - Turchia 76
CO - Colombia 70
PK - Pakistan 69
ID - Indonesia 66
VE - Venezuela 55
JP - Giappone 51
UZ - Uzbekistan 47
CL - Cile 45
PH - Filippine 43
PL - Polonia 38
MA - Marocco 36
SA - Arabia Saudita 36
MY - Malesia 34
TN - Tunisia 33
AT - Austria 29
PY - Paraguay 29
KR - Corea 24
PE - Perù 24
UA - Ucraina 22
ES - Italia 21
KE - Kenya 20
TH - Thailandia 20
EG - Egitto 19
JO - Giordania 19
SE - Svezia 19
AE - Emirati Arabi Uniti 18
AU - Australia 16
NP - Nepal 15
BO - Bolivia 14
FI - Finlandia 14
IR - Iran 14
UY - Uruguay 13
AL - Albania 12
GT - Guatemala 12
LB - Libano 12
TW - Taiwan 12
KZ - Kazakistan 11
AZ - Azerbaigian 10
HN - Honduras 10
IL - Israele 10
OM - Oman 10
DO - Repubblica Dominicana 9
IE - Irlanda 9
CI - Costa d'Avorio 8
ET - Etiopia 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
SN - Senegal 8
BG - Bulgaria 7
CR - Costa Rica 7
JM - Giamaica 7
LT - Lituania 7
NI - Nicaragua 7
PA - Panama 7
RO - Romania 7
BY - Bielorussia 6
CY - Cipro 6
DZ - Algeria 6
AM - Armenia 5
BH - Bahrain 5
GE - Georgia 5
HU - Ungheria 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AO - Angola 4
DK - Danimarca 4
GR - Grecia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
HR - Croazia 3
MK - Macedonia 3
MN - Mongolia 3
MU - Mauritius 3
NG - Nigeria 3
SV - El Salvador 3
BF - Burkina Faso 2
Totale 18.787
Città #
Singapore 1.772
San Jose 1.739
Hong Kong 954
Boardman 505
Ho Chi Minh City 492
Santa Clara 413
Ashburn 399
Johannesburg 383
Lauterbourg 319
Dallas 306
Hanoi 302
Los Angeles 217
Beijing 136
Moscow 133
São Paulo 131
New York 109
Buffalo 82
Columbus 60
Da Nang 60
Milan 60
Rio de Janeiro 56
Shanghai 45
Haiphong 44
Tashkent 44
Hefei 42
Tokyo 40
Brooklyn 39
Munich 37
Baghdad 35
Warsaw 35
Belo Horizonte 34
Mexico City 34
Hải Dương 33
Montreal 33
Biên Hòa 32
Nuremberg 31
Parma 31
Medellín 30
Quito 29
Toronto 29
Chennai 28
Brasília 26
Council Bluffs 26
Frankfurt am Main 26
Orem 26
Guayaquil 25
Dhaka 24
Naples 24
Caracas 22
Guarulhos 22
San Francisco 22
Porto Alegre 21
Rome 21
Chicago 20
Curitiba 20
Lahore 20
Fortaleza 19
Mumbai 19
Phoenix 19
Santiago 19
Amman 18
Thái Bình 18
Bắc Ninh 17
Kuala Lumpur 17
Lima 17
Assago 16
Can Tho 16
Denver 16
Nairobi 16
Guangzhou 15
Karachi 15
London 15
Ribeirão Preto 15
Riyadh 15
Atlanta 14
Campinas 14
Secaucus 14
Tianjin 14
Buenos Aires 13
Charlotte 13
Rio Claro 13
Stockholm 13
Bologna 12
Bắc Giang 12
Jakarta 12
Jeddah 12
Montevideo 12
Quảng Ngãi 12
Sydney 12
The Dalles 12
Thái Nguyên 12
Istanbul 11
Manaus 11
Nha Trang 11
Sorocaba 11
Ankara 10
Asunción 10
Boston 10
Cape Town 10
Changsha 10
Totale 10.290
Nome #
Onset of ANCA-positive EGPA with bilateral pleural effusion: a case report 141
Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease 132
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease 116
Adverse roles of mast cell chymase-1 in COPD 107
Methotrexate in the treatment of systemic glucocorticoid dependent severe persistent astma: a word of caution 107
A rare case of sudden blindness following mepolizumab withdrawal in EGPA 106
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 100
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 98
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 97
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive 95
Poxviridae Pneumonia 94
Ultrasound for assessment of diaphragm function in late-onset Pompe disease 92
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future 89
Airway obstruction in chronic obstructive pulmonary disease 86
A case of fibrosing interstitial pneumonia 83
Pathology of Asthma 82
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 81
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 79
Auto-antibodies against carbonyl-modified vimentin in COPD: potential role as a biomarker 78
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 78
Activation of NF-kappaB transcription factor in asthma death 78
Role of ATG4 Autophagy-Related Protein Family in the Lower Airways of Patients with Stable COPD 78
Allergen Responses Modified by a GATA3 DNAzyme 77
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 77
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 76
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview 75
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology 75
Stem Cells/Lung Organoids and Lung Rejuvenation in the Treatment of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 74
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive 73
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 73
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 73
Retraction Note: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide (Respiratory Research, (2018), 19, 1, (85), 10.1186/s12931-018-0788-x) 73
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 73
Posttranscriptional regulation of airway epithelial responses by the RNA binding protein AUF-1 72
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio 72
Glucocorticoidi per via inalatoria nel trattamento della patologia polmonare dell’adulto 71
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 71
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 70
Transcription factors in asthma and COPD 70
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 69
Decreased T-lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease 69
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 68
Alterations of humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease 68
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 67
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 67
Anatomia e fisiologia clinica della pleura 67
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 67
A link between lung injury and inflammatory myopathies: making the diagnosis 67
Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study 67
Delivery systems e protocollo di Montreal 66
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 66
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 66
La teofillina nella BPCO: nuove prospettive (3° parte) 66
Transcription Factors 66
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease 65
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 65
Marcatori infiammatori nella diagnosi e nel monitoraggio dell’ asma 65
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 65
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 65
Implementazione delle linee guida sull’asma bronchiale in Italia: l’opinione del medico di medicina generale 65
Expression of heme-oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effects of inhaled corticosteroids 64
Mechanisms of respiratory virus-induced asthma exacerbations 64
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 64
Physiologic consequences of long-term inflammation 64
Ruolo delle chinine nella patologia polmonare dell'adulto 63
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO) 63
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 63
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto 63
FN3K expression in COPD: A potential comorbidity factor for cardiovascular disease 63
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease 62
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 62
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease (vol 7, e000714, 2020) 62
Clinical definition of COPD exacerbations and classification of their severity 61
Sex differences and disparities in cardiovascular outcomes of COVID-19 61
Basi fisiopatologiche per la diagnosi delle malattie della pleura nell’adulto. Parte 1 61
Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer 61
Controllo dell’asma e delle BPCO nella medicina Generale 60
Sintesi delle nuove linee guida internazionali per la terapia farmacologica dell’asma 60
Oxidants and asthma 60
Sport e inquinamento atmosferico 60
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione 60
IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection 60
Nuove linee guida internazionali per la terapia farmacologica dell’asma 60
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 59
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia 59
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 59
Chronic obstructive pulmonary disease international guidelines 59
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature 59
Molecular mechanisms of respiratory virus-induced inflammation 59
Quality of life in asthma and COPD: is it measurable in primary care? 59
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 58
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare 58
Overlap and common correlates between depression and COPD: a narrative review 58
Classificazione e metodi di indagine del pneumotorace 58
Molecular links between COPD and lung cancer: new targets for drug discovery? 58
Ruolo delle infezioni respiratorie nelle riacutizzazioni di BPCO [Role of respiratory infections in COPD exacerbations] 57
Definizione e basi biologiche della broncopneumopatia cronica ostruttiva 57
Nuove strategie terapeutiche delle broncopneumopatie croniche ostruttive 57
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 57
Manifestazioni cliniche delle broncopneumopatie croniche ostruttive 57
Totale 7.147
Categoria #
all - tutte 77.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024943 0 0 0 0 343 30 43 6 21 97 103 300
2024/20255.140 21 401 373 28 525 400 120 120 945 684 341 1.182
2025/202613.119 865 1.474 1.862 1.144 1.633 374 2.006 374 1.500 1.021 457 409
Totale 19.202